Reversal of senescence-associated beta-galactosidase expression during in vitro three-dimensional tissue-engineering of human chondrocytes in a polymer scaffold

Abstract Regenerative medicine applications require cells that are not inflicted with senescence after in vitro culture for an optimal in vivo outcome. Methods to overcome replicative senescence include genomic modifications which have their own disadvantages. We have evaluated a three-dimensional (...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Shojiro Katoh, Atsuki Fujimaru, Masaru Iwasaki, Hiroshi Yoshioka, Rajappa Senthilkumar, Senthilkumar Preethy, Samuel J. K. Abraham
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/b5c0cbb496654a6aaf0d40704c94d2db
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:b5c0cbb496654a6aaf0d40704c94d2db
record_format dspace
spelling oai:doaj.org-article:b5c0cbb496654a6aaf0d40704c94d2db2021-12-02T15:23:16ZReversal of senescence-associated beta-galactosidase expression during in vitro three-dimensional tissue-engineering of human chondrocytes in a polymer scaffold10.1038/s41598-021-93607-92045-2322https://doaj.org/article/b5c0cbb496654a6aaf0d40704c94d2db2021-07-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-93607-9https://doaj.org/toc/2045-2322Abstract Regenerative medicine applications require cells that are not inflicted with senescence after in vitro culture for an optimal in vivo outcome. Methods to overcome replicative senescence include genomic modifications which have their own disadvantages. We have evaluated a three-dimensional (3D) thermo-reversible gelation polymer (TGP) matrix environment for its capabilities to reverse cellular senescence. The expression of senescence-associated beta-galactosidase (SA-βgal) by human chondrocytes from osteoarthritis-affected cartilage tissue, grown in a conventional two-dimensional (2D) monolayer culture versus in 3D-TGP were compared. In 2D, the cells de-differentiated into fibroblasts, expressed higher SA-βgal and started degenerating at 25 days. SA-βgal levels decreased when the chondrocytes were transferred from the 2D to the 3D-TGP culture, with cells exhibiting a tissue-like growth until 42–45 days. Other senescence associated markers such as p16INK4a and p21 were also expressed only in 2D cultured cells but not in 3D-TGP tissue engineered cartilage. This is a first-of-its-kind report of a chemically synthesized and reproducible in vitro environment yielding an advantageous reversal of aging of human chondrocytes without any genomic modifications. The method is worth consideration as an optimal method for growing cells for regenerative medicine applications.Shojiro KatohAtsuki FujimaruMasaru IwasakiHiroshi YoshiokaRajappa SenthilkumarSenthilkumar PreethySamuel J. K. AbrahamNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Shojiro Katoh
Atsuki Fujimaru
Masaru Iwasaki
Hiroshi Yoshioka
Rajappa Senthilkumar
Senthilkumar Preethy
Samuel J. K. Abraham
Reversal of senescence-associated beta-galactosidase expression during in vitro three-dimensional tissue-engineering of human chondrocytes in a polymer scaffold
description Abstract Regenerative medicine applications require cells that are not inflicted with senescence after in vitro culture for an optimal in vivo outcome. Methods to overcome replicative senescence include genomic modifications which have their own disadvantages. We have evaluated a three-dimensional (3D) thermo-reversible gelation polymer (TGP) matrix environment for its capabilities to reverse cellular senescence. The expression of senescence-associated beta-galactosidase (SA-βgal) by human chondrocytes from osteoarthritis-affected cartilage tissue, grown in a conventional two-dimensional (2D) monolayer culture versus in 3D-TGP were compared. In 2D, the cells de-differentiated into fibroblasts, expressed higher SA-βgal and started degenerating at 25 days. SA-βgal levels decreased when the chondrocytes were transferred from the 2D to the 3D-TGP culture, with cells exhibiting a tissue-like growth until 42–45 days. Other senescence associated markers such as p16INK4a and p21 were also expressed only in 2D cultured cells but not in 3D-TGP tissue engineered cartilage. This is a first-of-its-kind report of a chemically synthesized and reproducible in vitro environment yielding an advantageous reversal of aging of human chondrocytes without any genomic modifications. The method is worth consideration as an optimal method for growing cells for regenerative medicine applications.
format article
author Shojiro Katoh
Atsuki Fujimaru
Masaru Iwasaki
Hiroshi Yoshioka
Rajappa Senthilkumar
Senthilkumar Preethy
Samuel J. K. Abraham
author_facet Shojiro Katoh
Atsuki Fujimaru
Masaru Iwasaki
Hiroshi Yoshioka
Rajappa Senthilkumar
Senthilkumar Preethy
Samuel J. K. Abraham
author_sort Shojiro Katoh
title Reversal of senescence-associated beta-galactosidase expression during in vitro three-dimensional tissue-engineering of human chondrocytes in a polymer scaffold
title_short Reversal of senescence-associated beta-galactosidase expression during in vitro three-dimensional tissue-engineering of human chondrocytes in a polymer scaffold
title_full Reversal of senescence-associated beta-galactosidase expression during in vitro three-dimensional tissue-engineering of human chondrocytes in a polymer scaffold
title_fullStr Reversal of senescence-associated beta-galactosidase expression during in vitro three-dimensional tissue-engineering of human chondrocytes in a polymer scaffold
title_full_unstemmed Reversal of senescence-associated beta-galactosidase expression during in vitro three-dimensional tissue-engineering of human chondrocytes in a polymer scaffold
title_sort reversal of senescence-associated beta-galactosidase expression during in vitro three-dimensional tissue-engineering of human chondrocytes in a polymer scaffold
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/b5c0cbb496654a6aaf0d40704c94d2db
work_keys_str_mv AT shojirokatoh reversalofsenescenceassociatedbetagalactosidaseexpressionduringinvitrothreedimensionaltissueengineeringofhumanchondrocytesinapolymerscaffold
AT atsukifujimaru reversalofsenescenceassociatedbetagalactosidaseexpressionduringinvitrothreedimensionaltissueengineeringofhumanchondrocytesinapolymerscaffold
AT masaruiwasaki reversalofsenescenceassociatedbetagalactosidaseexpressionduringinvitrothreedimensionaltissueengineeringofhumanchondrocytesinapolymerscaffold
AT hiroshiyoshioka reversalofsenescenceassociatedbetagalactosidaseexpressionduringinvitrothreedimensionaltissueengineeringofhumanchondrocytesinapolymerscaffold
AT rajappasenthilkumar reversalofsenescenceassociatedbetagalactosidaseexpressionduringinvitrothreedimensionaltissueengineeringofhumanchondrocytesinapolymerscaffold
AT senthilkumarpreethy reversalofsenescenceassociatedbetagalactosidaseexpressionduringinvitrothreedimensionaltissueengineeringofhumanchondrocytesinapolymerscaffold
AT samueljkabraham reversalofsenescenceassociatedbetagalactosidaseexpressionduringinvitrothreedimensionaltissueengineeringofhumanchondrocytesinapolymerscaffold
_version_ 1718387286848045056